Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer
SourceBritish Journal of Cancer, 76, 10, (1997), pp. 1376-1381
Article / Letter to editor
Display more detailsDisplay less details
British Journal of Cancer
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.